| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.61 | 0.03 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.06 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.17 | 0.007 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.15 | 0.07 |